Patent ID: 9161930
Filing Date: 2015-10-20
Classification: A61K,A61P

Abstract:
1. A method for treating diabetic nephropathy in a subject comprising the steps of: a). providing a pharmaceutical composition consisting of 4, 4′-diphenylmethane-bis(methyl) carbamates (DPMC) and at least one pharmaceutically acceptable drug carrier, wherein the 4, 4′-diphenylmethane-bis(methyl) carbamates (DPMC) is in a percentage of 0.1-99.5% by weight of the pharmaceutical composition, and the pharmaceutical composition is administered in a clinical dosage form selected from the group consisting of: (1) a pellet pill consisting of 4, 4′-diphenylmethane-bis(methyl) carbamates (DPMC), lactose, Amylum maydis, and magnesium stearate, and (2) a drop pill consisting of 4, 4′-diphenylmethane-bis(methyl) carbamates (DPMC), polyglycol 6000, and dimethyl benzene silicon oil, and (b). administering an effective amount of the pharmaceutical composition in a clinical dosage form to a patient in need thereof, wherein the effective amount of 4, 4′-diphenylmethane-bis (methyl) carbamates (DPMC) is 20-120 mg per day.